Poulin Y - Search Results

1

Impact of ixekizumab treatment on skin-related personal relationship difficulties in moderate-to-severe psoriasis patients: 12-week results from two Phase 3 trials.

Guenther L, Warren RB, Cather JC, Sofen H, Poulin Y, Lebwohl M, Terui T, Potts Bleakman A, Zhu B, Burge R, Reich K, van de Kerkhof P. Guenther L, et al. Among authors: poulin y. J Eur Acad Dermatol Venereol. 2017 Nov;31(11):1867-1875. doi: 10.1111/jdv.14377. Epub 2017 Sep 4. J Eur Acad Dermatol Venereol. 2017. PMID: 28573743 Clinical Trial.

2

Tazarotene in combination with topical corticosteroids.

Lebwohl M, Poulin Y. Lebwohl M, et al. Among authors: poulin y. J Am Acad Dermatol. 1998 Oct;39(4 Pt 2):S139-43. doi: 10.1016/s0190-9622(98)70311-1. J Am Acad Dermatol. 1998. PMID: 9777792 Review.

3

A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis.

Guenther LC, Poulin YP, Pariser DM. Guenther LC, et al. Among authors: poulin yp. Clin Ther. 2000 Oct;22(10):1225-38. doi: 10.1016/s0149-2918(00)83065-9. Clin Ther. 2000. PMID: 11110233 Clinical Trial.

4

Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel.

Rivers JK, Arlette J, Shear N, Guenther L, Carey W, Poulin Y. Rivers JK, et al. Among authors: poulin y. Br J Dermatol. 2002 Jan;146(1):94-100. doi: 10.1046/j.1365-2133.2002.04561.x. Br J Dermatol. 2002. PMID: 11841372 Clinical Trial.

5

A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.

Webster GF, Guenther L, Poulin YP, Solomon BA, Loven K, Lee J. Webster GF, et al. Cutis. 2002 Feb;69(2 Suppl):4-11. Cutis. 2002. PMID: 12095066 Clinical Trial.

6

Incorporating biologics into the treatment of psoriasis.

Lui H, Langley R, Poulin Y, Gupta AK, Carey W, Guenther L, Searles G, Toole J, Lynde C, Gulliver W, Barber K. Lui H, et al. Among authors: poulin y. J Cutan Med Surg. 2004 Aug;8 Suppl:8-13. doi: 10.1007/s10227-004-2003-6. J Cutan Med Surg. 2004. PMID: 15655584 Review. No abstract available.

7

The use of alefacept in the treatment of psoriasis.

Langley R, Gupta AK, Poulin Y, Guenther L, Barber K, Gulliver W, Lynde C. Langley R, et al. Among authors: poulin y. J Cutan Med Surg. 2004 Aug;8 Suppl:14-8. doi: 10.1007/s10227-004-2004-5. J Cutan Med Surg. 2004. PMID: 15655585 Review. No abstract available.

8

Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004.

Guenther L, Langley RG, Shear NH, Bissonnette R, Ho V, Lynde C, Murray E, Papp K, Poulin Y, Zip C. Guenther L, et al. Among authors: poulin y. J Cutan Med Surg. 2004 Sep-Oct;8(5):321-37. doi: 10.1007/s10227-005-0035-1. J Cutan Med Surg. 2004. PMID: 15868311

9

XP-828l in the treatment of mild to moderate psoriasis: randomized, double-blind, placebo-controlled study.

Poulin Y, Bissonnette R, Juneau C, Cantin K, Drouin R, Poubelle PE. Poulin Y, et al. J Cutan Med Surg. 2006 Sep-Oct;10(5):241-8. doi: 10.2310/7750.2006.00049. J Cutan Med Surg. 2006. PMID: 17234108 Clinical Trial.

10

XP-828L in the treatment of mild to moderate psoriasis: randomized, double-blind, placebo-controlled study.

Poulin Y, Bissonnette R, Juneau C, Cantin K, Drouin R, Poubelle PE. Poulin Y, et al. Altern Med Rev. 2007 Dec;12(4):352-9. Altern Med Rev. 2007. PMID: 18069904 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page